InvestorsHub Logo
Followers 50
Posts 5108
Boards Moderated 0
Alias Born 06/18/2009

Re: creede post# 45

Friday, 05/06/2011 8:17:25 AM

Friday, May 06, 2011 8:17:25 AM

Post# of 244
From their last 10Q:

http://www.sec.gov/Archives/edgar/data/1030839/000093041309004832/c58796_10-q.htm

"The Company’s subsidiaries Kirk and ANDAPharm entered into a Contract Manufacturing Agreement dated July 1, 2009 (the “Contract Manufacturing Agreement”) with an affiliate of Maneesh, Svizera USA LLC (“Svizera USA”)."

"A critical key to this strategy and its implementation is our alliance with Maneesh Pharmaceuticals Ltd. (“Maneesh”) and Harcharan (Harry) Singh of Glopec International. Maneesh is an international pharmaceutical company with its headquarters located in Mumbai, India. Harry Singh is a pharmaceutical industry veteran with a 20 year proven track record of sourcing competitive pharmaceuticals products for North America from Asia and Europe"

"More recently, we have entered into a contract manufacturing agreement with an affiliate of Maneesh for the manufacture and sale of finish dose forms of product. Maneesh has a variety of drug development and manufacturing facilities in various locations throughout the world, although we are coordinating principally with the operations in India. Harry Singh has a long standing business relationships with numerous other pharmaceutical companies in India (and their owners) and is directing many of our steps in arranging agreements for ANDA in-licensing, low-cost APIs and specialty contract manufacturing. We source finished product internationally, then package and distribute through Florida; the customer belongs to Synovics."

http://www.svizera.com/
http://www.glopec.com/

Big boys involved?...
mmmmm.....


....

All my posts are purely my opinion and are not a buy/sell recommendation . Never buy or sell securities based on my opinion. I reserve the right to buy/sell any stock or any security I post about or not. Always do your own DD.